🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This randomized phase II trial studies how well pembrolizumab with or witho...
Status
Completed
Location
Anchorage Associates in Radiation Medicine
Start Date
2018-06-12
Trial ID
NCT03304639
Treatments Being Tested
The primary goal of the study was to evaluate the parameters of efficacy, p...
Status
Terminated
Location
Moscow City State Healthcare Institution "O.M. Filatov Municipal Clinical Hospital No. 15" of the Moscow Department of Healthcare
Start Date
2018-03-26
Trial ID
NCT04067492
This phase Ib trial tests the safety and tolerability of ZEN003694 in combi...
Status
Recruiting
Location
Boston Medical Center
Start Date
2023-05-18
Trial ID
NCT05422794
This phase I trial tests the safety, side effects, and best dose of tazemet...
Status
Active Not Recruiting
Location
Keck Medicine of USC Koreatown
Start Date
2022-07-27
Trial ID
NCT05353439
This phase II trial studies the effect of pembrolizumab alone compared to t...
Status
Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2021-04-27
Trial ID
NCT04671667
This phase II trial compares therapeutic plasma exchange followed by enfort...
Status
Recruiting
Location
Mayo Clinic in Rochester
Start Date
2025-08-01
Trial ID
NCT07087860
This phase II trial compares the effect of adding ipatasertib to pembrolizu...
Status
Active Not Recruiting
Location
City of Hope Comprehensive Cancer Center
Start Date
2022-07-26
Trial ID
NCT05172258
Treatments Being Tested
This phase II trial tests the effect of giving pembrolizumab in combination...
Status
Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2025-11-25
Trial ID
NCT07061964
This phase Ib/II trial tests the safety, side effects, and best dose of que...
Status
Not Yet Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2026-12-01
Trial ID
NCT07667335
This phase Ib trial tests the safety, side effects and best dose of tumor m...
Status
Recruiting
Location
Emory University Hospital Midtown
Start Date
2025-05-08
Trial ID
NCT06868433